James La Rossa, Jr. is the publisher of the Psychopharmacology Bulletin and a long time support of mine here and in comments at the Carlat blog. James has always stepped up to show support for me and my daughter and we've had interesting and lively discussions in comment sections--though our opinions of medication use can differ, we both speak from personal experience, and I hold a high esteem for La Rossa. But...
Unfortunately, I have found a conflict that James may be aware of or not--with his Editor Michael Thase. Thase is well-known in the bipolar treatment world--a KOL who has his hand in the pharma cash cookie jar.
Thase is in the ProPublica Dollars for Docs database.
MONEY TAKEN FROM ASTRAZENECA, ELI LILLY AND GSK (makers of Seroquel ,Zyprexa and Paxil just to name a few)
THASE, MICHAEL EDWARD Pa. Pittsburgh
Eli Lilly $20,325 2009
Q1-Q4 Healthcare Professional Education Programs: $20325.0
THASE, MICHAEL EDWARD
Thase, Michael Pa. Moylan AstraZeneca $39,750 2010
Q1-Q2 Speaker compensation MICHAEL THASE WESTERN PSYCH INST & CLINIC
Thase, Michael Pa. Philadelphia GSK $250 2009
Q2-Q4 Consulting: $0.00 Speaking: $250 Michael Thase
--
In 1997, Thase was course director of the Second International Conference on Bipolar Disorder along with conflicted KOL Joseph Biederman, another participant. With heavy pharma influence via personal bank accounts, would you consider their opinion on the treatment of bipolar disorder to be unbiased? or pro-medication? Think about it.
Another article featuring Thase from Furious Seasons-blog on hiatus.
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment